Login

Skyfii Ltd CEO and co-founder Wayne Arthur discusses the company's December quarter highlights with Proactive's Elisha Newell. 00:10:00

Share On Facebook Share On Twitter

Antony Karp is Former Interim CEO at Skyfii Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unlocking the Potential of Employee Stock Options | Robbie Scoonmaker, CFP, Matterhorn Financial Planning
00:10:00
CEO Discusses Strong Profit Contributions and News Flow in Recent Quarter | Per-Erik Eriksson , CEO, Arise AB.
00:10:00
Condoleezza Rice Discusses 9/11, Iraq, and Her Career on Uncommon Knowledge
00:10:00
Navigating the Evolving Landscape of New Energy Materials
00:10:00
Advancing Exploration and Development: Hay Street Project in Australia's Northern Territory
00:10:00
Understanding the Macroeconomic Landscape: Dr. Victor A. Abola
00:10:00
Fritz Zurbrügg: "Presentation of the New 100-Franc Note: Key Design and Security Features" with Thomas Jordan
00:10:00
"Insights into Jones Day's Global Investigations & White Collar Defense Practice" | THEODORE T.CHUNG (TED) - Practice Leader Investigations & White Collar Defense, Jones Day
00:10:00
Insights from Ariel Investments' Co-CEO on Market Strategies
00:10:00
Kit Mars on Western Alaska Minerals: High-Grade Discoveries and Strategic Drilling Plans
00:10:00
Mike interviewed Mac Holley of Heritage Capital Group and the CEO of Bluhorn Solutions about business strategies and White's commitment to innovation.
00:10:00
Prince Hans Adam II on Transforming the State into a Service Company|Hans-Adam

© 2017 - Neuhu+